| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T86 |
0-201 |
Sentence |
denotes |
The rate of pathologic complete response (pCR) is higher in HER2 overexpressing (HER2+) and triple-negative (TN) breast cancers, and less frequent in the more common hormone- receptor-positive cancers. |
| T87 |
202-436 |
Sentence |
denotes |
As a result, TN and Her2 + breast cancer patients with T2 or larger tumor or LN involvement are candidates for neoadjuvant therapy, and there was no significant difference in the approach in these patients during the pandemic process. |
| T88 |
437-542 |
Sentence |
denotes |
Patients with T1N0M0 disease also encouraged to have NAC before surgery during the COVID-19 pandemic.[12] |
